Selected research
Industry Research
Parenteral Nutrition Solutions Industry Research Report 2026
Market perspective
The global Parenteral Nutrition Solutions market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Parenteral Nutrition Solutions market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Parenteral Nutrition Solutions market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Parenteral Nutrition Solutions market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Parenteral Nutrition Solutions include Teva Pharmaceutical Industries, Pfizer (Hospira), Fresenius, B. Braun, Baxter International Inc., PSI Ltd, Pisa, Patheon and Ozon Pharmaceuticals, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Parenteral Nutrition Solutions market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Parenteral Nutrition Solutions.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Parenteral Nutrition Solutions Market by Company
Teva Pharmaceutical Industries
Pfizer (Hospira)
Fresenius
B. Braun
Baxter International Inc.
PSI Ltd
Pisa
Patheon
Ozon Pharmaceuticals
Ostuka Pharmaceutical
Kelun Pharma
Huaren
CR Double-Crane
Cook Pharmica
BML Parenteral Drugs
Beximco Pharma
BAG Healthcare
Aspen Holdings
Albert David
Parenteral Nutrition Solutions Segment by Type
Large Volume Parenteral (LVP)
Small Volume Parenteral (SVP)
Parenteral Nutrition Solutions Segment by Application
Basic Infusion
Nutritious Infusion
Therapeutic Infusion
Parenteral Nutrition Solutions Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Parenteral Nutrition Solutions market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Parenteral Nutrition Solutions and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Parenteral Nutrition Solutions.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Parenteral Nutrition Solutions companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Large Volume Parenteral (LVP)
- Small Volume Parenteral (SVP)
Applications
- Basic Infusion
- Nutritious Infusion
- Therapeutic Infusion
Companies covered
- Teva Pharmaceutical Industries
- Pfizer (Hospira)
- Fresenius
- B. Braun
- Baxter International Inc.
- PSI Ltd
- Pisa
- Patheon
- Ozon Pharmaceuticals
- Ostuka Pharmaceutical
- Kelun Pharma
- Huaren
- CR Double-Crane
- Cook Pharmica
- BML Parenteral Drugs
- Beximco Pharma
- BAG Healthcare
- Aspen Holdings
- Albert David
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Parenteral Nutrition Solutions by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Large Volume Parenteral (LVP)
- 2.2.3 Small Volume Parenteral (SVP)
- 2.3 Parenteral Nutrition Solutions by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Basic Infusion
- 2.3.3 Nutritious Infusion
- 2.3.4 Therapeutic Infusion
- 2.4 Assumptions and Limitations
3 Parenteral Nutrition Solutions Breakdown Data by Type
- 3.1 Global Parenteral Nutrition Solutions Historic Market Size by Type (2021-2026)
- 3.2 Global Parenteral Nutrition Solutions Forecasted Market Size by Type (2027-2032)
4 Parenteral Nutrition Solutions Breakdown Data by Application
- 4.1 Global Parenteral Nutrition Solutions Historic Market Size by Application (2021-2026)
- 4.2 Global Parenteral Nutrition Solutions Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Parenteral Nutrition Solutions Market Perspective (2021-2032)
- 5.2 Global Parenteral Nutrition Solutions Growth Trends by Region
- 5.2.1 Global Parenteral Nutrition Solutions Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Parenteral Nutrition Solutions Historic Market Size by Region (2021-2026)
- 5.2.3 Parenteral Nutrition Solutions Forecasted Market Size by Region (2027-2032)
- 5.3 Parenteral Nutrition Solutions Market Dynamics
- 5.3.1 Parenteral Nutrition Solutions Industry Trends
- 5.3.2 Parenteral Nutrition Solutions Market Drivers
- 5.3.3 Parenteral Nutrition Solutions Market Challenges
- 5.3.4 Parenteral Nutrition Solutions Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Parenteral Nutrition Solutions Players by Revenue
- 6.1.1 Global Top Parenteral Nutrition Solutions Players by Revenue (2021-2026)
- 6.1.2 Global Parenteral Nutrition Solutions Revenue Market Share by Players (2021-2026)
- 6.2 Global Parenteral Nutrition Solutions Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Parenteral Nutrition Solutions Head Office and Area Served
- 6.4 Global Parenteral Nutrition Solutions Players, Product Type & Application
- 6.5 Global Parenteral Nutrition Solutions Manufacturers Established Date
- 6.6 Global Parenteral Nutrition Solutions Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Parenteral Nutrition Solutions Market Size (2021-2032)
- 7.2 North America Parenteral Nutrition Solutions Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Parenteral Nutrition Solutions Market Size by Country (2021-2026)
- 7.4 North America Parenteral Nutrition Solutions Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Parenteral Nutrition Solutions Market Size (2021-2032)
- 8.2 Europe Parenteral Nutrition Solutions Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Parenteral Nutrition Solutions Market Size by Country (2021-2026)
- 8.4 Europe Parenteral Nutrition Solutions Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Parenteral Nutrition Solutions Market Size (2021-2032)
- 9.2 Asia-Pacific Parenteral Nutrition Solutions Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Parenteral Nutrition Solutions Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Parenteral Nutrition Solutions Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Parenteral Nutrition Solutions Market Size (2021-2032)
- 10.2 South America Parenteral Nutrition Solutions Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Parenteral Nutrition Solutions Market Size by Country (2021-2026)
- 10.4 South America Parenteral Nutrition Solutions Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Parenteral Nutrition Solutions Market Size (2021-2032)
- 11.2 Middle East & Africa Parenteral Nutrition Solutions Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Parenteral Nutrition Solutions Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Parenteral Nutrition Solutions Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Teva Pharmaceutical Industries
- 12.1.1 Teva Pharmaceutical Industries Company Information
- 12.1.2 Teva Pharmaceutical Industries Business Overview
- 12.1.3 Teva Pharmaceutical Industries Revenue in Parenteral Nutrition Solutions Business (2021-2026)
- 12.1.4 Teva Pharmaceutical Industries Parenteral Nutrition Solutions Product Portfolio
- 12.1.5 Teva Pharmaceutical Industries Recent Developments
- 12.2 Pfizer (Hospira)
- 12.2.1 Pfizer (Hospira) Company Information
- 12.2.2 Pfizer (Hospira) Business Overview
- 12.2.3 Pfizer (Hospira) Revenue in Parenteral Nutrition Solutions Business (2021-2026)
- 12.2.4 Pfizer (Hospira) Parenteral Nutrition Solutions Product Portfolio
- 12.2.5 Pfizer (Hospira) Recent Developments
- 12.3 Fresenius
- 12.3.1 Fresenius Company Information
- 12.3.2 Fresenius Business Overview
- 12.3.3 Fresenius Revenue in Parenteral Nutrition Solutions Business (2021-2026)
- 12.3.4 Fresenius Parenteral Nutrition Solutions Product Portfolio
- 12.3.5 Fresenius Recent Developments
- 12.4 B. Braun
- 12.4.1 B. Braun Company Information
- 12.4.2 B. Braun Business Overview
- 12.4.3 B. Braun Revenue in Parenteral Nutrition Solutions Business (2021-2026)
- 12.4.4 B. Braun Parenteral Nutrition Solutions Product Portfolio
- 12.4.5 B. Braun Recent Developments
- 12.5 Baxter International Inc.
- 12.5.1 Baxter International Inc. Company Information
- 12.5.2 Baxter International Inc. Business Overview
- 12.5.3 Baxter International Inc. Revenue in Parenteral Nutrition Solutions Business (2021-2026)
- 12.5.4 Baxter International Inc. Parenteral Nutrition Solutions Product Portfolio
- 12.5.5 Baxter International Inc. Recent Developments
- 12.6 PSI Ltd
- 12.6.1 PSI Ltd Company Information
- 12.6.2 PSI Ltd Business Overview
- 12.6.3 PSI Ltd Revenue in Parenteral Nutrition Solutions Business (2021-2026)
- 12.6.4 PSI Ltd Parenteral Nutrition Solutions Product Portfolio
- 12.6.5 PSI Ltd Recent Developments
- 12.7 Pisa
- 12.7.1 Pisa Company Information
- 12.7.2 Pisa Business Overview
- 12.7.3 Pisa Revenue in Parenteral Nutrition Solutions Business (2021-2026)
- 12.7.4 Pisa Parenteral Nutrition Solutions Product Portfolio
- 12.7.5 Pisa Recent Developments
- 12.8 Patheon
- 12.8.1 Patheon Company Information
- 12.8.2 Patheon Business Overview
- 12.8.3 Patheon Revenue in Parenteral Nutrition Solutions Business (2021-2026)
- 12.8.4 Patheon Parenteral Nutrition Solutions Product Portfolio
- 12.8.5 Patheon Recent Developments
- 12.9 Ozon Pharmaceuticals
- 12.9.1 Ozon Pharmaceuticals Company Information
- 12.9.2 Ozon Pharmaceuticals Business Overview
- 12.9.3 Ozon Pharmaceuticals Revenue in Parenteral Nutrition Solutions Business (2021-2026)
- 12.9.4 Ozon Pharmaceuticals Parenteral Nutrition Solutions Product Portfolio
- 12.9.5 Ozon Pharmaceuticals Recent Developments
- 12.10 Ostuka Pharmaceutical
- 12.10.1 Ostuka Pharmaceutical Company Information
- 12.10.2 Ostuka Pharmaceutical Business Overview
- 12.10.3 Ostuka Pharmaceutical Revenue in Parenteral Nutrition Solutions Business (2021-2026)
- 12.10.4 Ostuka Pharmaceutical Parenteral Nutrition Solutions Product Portfolio
- 12.10.5 Ostuka Pharmaceutical Recent Developments
- 12.11 Kelun Pharma
- 12.11.1 Kelun Pharma Company Information
- 12.11.2 Kelun Pharma Business Overview
- 12.11.3 Kelun Pharma Revenue in Parenteral Nutrition Solutions Business (2021-2026)
- 12.11.4 Kelun Pharma Parenteral Nutrition Solutions Product Portfolio
- 12.11.5 Kelun Pharma Recent Developments
- 12.12 Huaren
- 12.12.1 Huaren Company Information
- 12.12.2 Huaren Business Overview
- 12.12.3 Huaren Revenue in Parenteral Nutrition Solutions Business (2021-2026)
- 12.12.4 Huaren Parenteral Nutrition Solutions Product Portfolio
- 12.12.5 Huaren Recent Developments
- 12.13 CR Double-Crane
- 12.13.1 CR Double-Crane Company Information
- 12.13.2 CR Double-Crane Business Overview
- 12.13.3 CR Double-Crane Revenue in Parenteral Nutrition Solutions Business (2021-2026)
- 12.13.4 CR Double-Crane Parenteral Nutrition Solutions Product Portfolio
- 12.13.5 CR Double-Crane Recent Developments
- 12.14 Cook Pharmica
- 12.14.1 Cook Pharmica Company Information
- 12.14.2 Cook Pharmica Business Overview
- 12.14.3 Cook Pharmica Revenue in Parenteral Nutrition Solutions Business (2021-2026)
- 12.14.4 Cook Pharmica Parenteral Nutrition Solutions Product Portfolio
- 12.14.5 Cook Pharmica Recent Developments
- 12.15 BML Parenteral Drugs
- 12.15.1 BML Parenteral Drugs Company Information
- 12.15.2 BML Parenteral Drugs Business Overview
- 12.15.3 BML Parenteral Drugs Revenue in Parenteral Nutrition Solutions Business (2021-2026)
- 12.15.4 BML Parenteral Drugs Parenteral Nutrition Solutions Product Portfolio
- 12.15.5 BML Parenteral Drugs Recent Developments
- 12.16 Beximco Pharma
- 12.16.1 Beximco Pharma Company Information
- 12.16.2 Beximco Pharma Business Overview
- 12.16.3 Beximco Pharma Revenue in Parenteral Nutrition Solutions Business (2021-2026)
- 12.16.4 Beximco Pharma Parenteral Nutrition Solutions Product Portfolio
- 12.16.5 Beximco Pharma Recent Developments
- 12.17 BAG Healthcare
- 12.17.1 BAG Healthcare Company Information
- 12.17.2 BAG Healthcare Business Overview
- 12.17.3 BAG Healthcare Revenue in Parenteral Nutrition Solutions Business (2021-2026)
- 12.17.4 BAG Healthcare Parenteral Nutrition Solutions Product Portfolio
- 12.17.5 BAG Healthcare Recent Developments
- 12.18 Aspen Holdings
- 12.18.1 Aspen Holdings Company Information
- 12.18.2 Aspen Holdings Business Overview
- 12.18.3 Aspen Holdings Revenue in Parenteral Nutrition Solutions Business (2021-2026)
- 12.18.4 Aspen Holdings Parenteral Nutrition Solutions Product Portfolio
- 12.18.5 Aspen Holdings Recent Developments
- 12.19 Albert David
- 12.19.1 Albert David Company Information
- 12.19.2 Albert David Business Overview
- 12.19.3 Albert David Revenue in Parenteral Nutrition Solutions Business (2021-2026)
- 12.19.4 Albert David Parenteral Nutrition Solutions Product Portfolio
- 12.19.5 Albert David Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst